Global Multi-Omics Market Growth is set to be driven by emerging demands for Personalized Medicine

1
Global Multi Omics Market - Collective
Technologies that define New Era for Integrative
Medicine
2

• The Global Multi-Omics Market which largely
  consists of Genomics, Transcriptomics,
  Proteomics, Metabonomics is set to witness
  double digit growth. The demand for personalised
  medicine, technical developments, a favourable
  funding environment, the increased prevalence of
  cancer and genetic disorders, and expanding
  pharmaceutical and biotech RD expenditure are
  projected to be the main drivers of the next
  phase of growth.
• The term "omics" has emerged as the new mantra in
  molecular research. It is a biological sciences
  research topic whose name ends with the suffix
  -omics. Numerous areas of research can be
  classified as omics such as genomics,
  transcriptomics, proteomics and metabolomics.
• Genomics studies genes and their function.
  Genomics finds application in drug discovery and
  development, diagnostics therapeutic
  decision-making, agriculture, animal research and
  other applications.
• Transcriptomics studies mRNAs. It is widely used
  for clinical diagnostics, drug discovery,
  toxicogenomics and other applications.
• Proteomics studies proteins. It is used for
  clinical diagnosis of cancer, infectious
  diseases, cardiovascular diseases, immune
  diseases, neurological disorders, diabetes, etc.
  and drug discovery.
• Metabonomics studies small molecules involved in
  cellular metabolism. It is a powerful research
  tool that is currently being applied to various
  aspects of drug and biomarker discovery,
  toxicology research, nutrigenomics and other
  applications

3
The interpretation of molecular complexity and
variations at several levels, including the
genome, transcriptome, proteome, and metabolome,
is necessary for a complete knowledge of human
health and disease. With the development of
sequencing technology, biology has depended
increasingly on the data generated at these
levels, sometimes known as "multi-omics" data.
Availability of Multi-Omics data has
revolutionized the field of medicine and biology.
Understanding causal relationships at various
levels of cellular organisation is facilitated by
data integration across many platforms (genomics,
transcriptomics, proteomics, and metabolomics).
It offers unparalleled opportunities to
understand the underlying biology of complex
diseases such as cancer. The advent of
multi-omics is turning scientists into molecular
detectives and helping them to delve into the
depths of disease. It allows researchers and
scientists to probe the more complex and
transient molecular changes that underpin the
course of disease and responses to treatment,
helping them better select the right drug
target. - Senior Director, Data Sciences
Quantitative Biology, Tier I   Pharmaceutical
Biotechnology Company Explore Premium Report on
Multi-omics Market _at_ https//meditechinsights.com/
multi-omics-market/
4
Single-cell Analysis Enters the Multi-Omics Era A
cell's condition can be defined by the interplay
between its genome, epigenome, transcriptome, and
proteome. Multi-Omics technologies for single
cells have evolved as a result of the advancement
of these omics technologies, allowing them to
capture data from numerous omic layers within the
same cell. Profiling multiple omic layers makes
it possible to capture a more complete set of
information about each cell than is possible from
any single omic layer alone. Single-cell
multi-omics are considered to be more powerful
than a stand-alone omics because they more
accurately represent the comprehensive network of
interactions that underlies cellular
functions. Single-cell multi-Omics technologies
are set to take center stage in biomedical
research as it enables the characterization of
cells and tissues at an unparalleled molecular
and architectural resolution. Competitive
Landscape Analysis of Multi-omics Market Some of
the key players operating in the global
multi-omics market are 10x Genomics, Bio-Techne
Corporation, Fluidigm Corporation, Bio-Rad
Laboratories, Inc., NanoString, Mission Bio, BD
Biosciences, Thermo Fisher Scientific Inc., among
others.
5
For More Detailed Insights, Contact Us
_at_ https//meditechinsights.com/contact-us/ About
Medi-Tech Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com